Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

235 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Completed

A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

NCT02594267

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Houston, Texas, United States
  • Seattle Cancer Care Alliance/University of Washington Seattle, Washington, United States
View Trial Details
Completed

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

NCT02676778

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #2 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #1 Kashiwa, Chiba, Japan
  • Eisai Trial Site #1 Ōta, Gunma, Japan
View all 20 locations
View Trial Details
Completed

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817

Conditions
Bone Marrow Transplant Failure, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

NCT00211185

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Birmingham Hematology and Oncology Birmingham, Alabama, United States
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Stanford Cancer Center Stanford, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View all 49 locations
View Trial Details

Related conditions